Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 13, 2024

SELL
$224.58 - $256.19 $13.1 Million - $15 Million
-58,500 Reduced 92.86%
4,500 $1.12 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $2.8 Million - $3.19 Million
-12,000 Reduced 16.0%
63,000 $15.6 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $562,475 - $640,350
2,500 Added 3.45%
75,000 $18 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $7.79 Million - $9 Million
32,500 Added 81.25%
72,500 $18.3 Million
Q4 2022

Sep 21, 2023

SELL
$241.42 - $282.29 $8.45 Million - $9.88 Million
-35,000 Reduced 46.67%
40,000 $10.6 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $9.66 Million - $11.3 Million
40,000 New
40,000 $10.6 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $201B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.